GLP-1 receptor agonists and kidney outcomes: a meta-analysis and systematic review
Cited in blog · The Lancet Diabetes & Endocrinology, 9(9), 559-565. · 2021
Sattar N, Lee MMY, Kristensen SL, et al (2021). GLP-1 receptor agonists and kidney outcomes: a meta-analysis and systematic review. The Lancet Diabetes & Endocrinology, 9(9), 559-565.
Authors
Sattar N, Lee MMY, Kristensen SL, et al
Research lens
Sattar N, Lee MMY, Kristensen SL, et al (2021). GLP-1 receptor agonists and kidney outcomes: a meta-analysis and systematic review. The Lancet Diabetes & Endocrinology, 9(9), 559-565.
- blog
- novartis-pacibekitug-inflammation-2026-09-03